Company Overview and News

2
Deutsche (DB) Reports Preliminary Q2 Profit, Stock Gains 8%

16h zacks
Deutsche Bank AG (DB - Free Report) has gained more than 8% on the NYSE following the release of its preliminary second-quarter 2018 results. The company expects to report income before income taxes of about €700 million ($834.8 million) and net income of nearly €400 million ($477 million) for the quarter.
HCS.PRB DB HCS HSB 0005 UBS HSEA UBS.PRDCL HSEB HSBC.PRA HSBC ULSGF HBCYF

0
Hong Kong regulator, banks launch blockchain-based trade finance platform

2018-07-17 theedgemarkets
HONG KONG (July 17): Hong Kong’s banking regulator and seven banks, including HSBC Holdings PLC and Standard Chartered PLC, on Tuesday said they will jointly launch a trade finance platform in September using blockchain technology.
HCS.PRB STAN DBSDY ATB HSNGF HCS 0011 HSB 0005 D05 HSNGY DBSDF STAB 580001 STAC SCBFF STAN 2888 HSEA HSEB HSBC.PRA HSBC HBCYF

0
Banks Are Facing a Squeeze From Trump's Trade War - Bloomberg

2018-07-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
HCS.PRB STAN HCS HSB 0005 580001 STAB STAN STAC 2888 SCBFF HSEA HSEB HSBC.PRA HSBC HBCYF

0
Banks facing squeeze from Trump's trade war

2018-07-16 malaymail
LONDON, July 16 — For banks that finance trade in Asia, the tariff war between the US and China couldn’t come at a worse time.
HCS.PRB STAN HCS HSB 0005 580001 STAB STAN STAC 2888 SCBFF HSEA HSEB HSBC.PRA HSBC HBCYF

0
Banks Are Facing a Squeeze From Trump's Trade War

2018-07-15 theedgemarkets
(July 16): For banks that finance trade in Asia, the tariff war between the U.S. and China couldn’t come at a worse time.
HCS.PRB STAN HCS HSB 0005 580001 STAB STAN STAC 2888 SCBFF HSEA HSEB HSBC.PRA HSBC HBCYF

0
Surging Housing Costs May Prompt India to Raise Rates Again - Bloomberg

2018-07-14 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
HSB HCS.PRB 0005 YESBANK HSEA HSEB 532648 YYBKY HSBC.PRA HCS HSBC HBCYF

0
France Woos U.K. Finance as Industry Reels From Brexit Paper - Bloomberg

2018-07-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
HCS.PRB MS.PRE MS.PRF MS.PRG MS.PRA HCS HSB 0005 MS.PRI MS.PRK HSEA HSEB MS HSBC.PRA HSBC HBCYF

3
Is WisdomTree Dynamic Currency Hedged International Equity Fund (DDWM) a Hot ETF Right Now?

2018-07-12 zacks
Designed to provide broad exposure to the Broad Developed World ETFs category of the U.S. equity market, the WisdomTree Dynamic Currency Hedged International Equity Fund (DDWM - Free Report) is a smart beta exchange traded fund launched on 01/07/2016.
HCS.PRB BP HCS BP.A BP.B DDWM HSB 0005 BP HSEA HSEB BPAQF HSBC.PRA HSBC HBCYF

0
BASF Playing China Matchmaker Should Worry U.S. - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
STAN BNPQY ULVR OGZD UNLNF HSB STAB STAC SCBFF STAN BFFAF HSBC.PRA HSBC SYT HBCYF HCS.PRB UL UN UNLYF BNPQF DDAIF HCS SYENF VLKAF 0005 BNPZY 580001 2888 HSEA HSEB BASFY BFA 81JK

5
MOVES-HSBC appoints Alexander Glawe as managing director

2018-07-11 reuters
July 11 (Reuters) - HSBC Holdings Plc said on Wednesday it had named Alexander Glawe managing director, head of Northern Europe Financial Sponsors, effective December.
HCS.PRB DSLV VIIX DGLD CSSLF VIIZ HCS CS HSB 0005 CSGKF UGLD UBS HSEA UBS.PRDCL HSEB ZIV USLV HSBC.PRA TVIX HSBC ULSGF HBCYF XIV

52
BlackRock & Citi Select Paris for Expansion Post-Brexit

2018-07-09 zacks
BlackRock Inc. (BLK - Free Report) and Citigroup (C - Free Report) have selected French capital Paris over London as their new base for operations post-Brexit, as per Financial Times. This is the result of the promise of a cut in the tax rate by the French president, Emmanuel Macron. BlackRock will offer alternate investment services throughout Europe and Asia from its office in Paris. The company currently manages €30 billion for its French clients and has 50 employees in Paris.
HCS.PRB BAC POOL C HCS BAC HSB 0005 BLK HSEA HSEB ICE HSBC.PRA HSBC HBCYF

4
Credit Suisse (CS) to Pay $77M Fine for China Hiring Scandal

2018-07-06 zacks
Credit Suisse Group AG (CS - Free Report) has agreed to pay $77 million in aggregate to the U.S. regulators to put an end to investigations related to the alleged violation of the Foreign Corrupt Practices Act (FCPA). The bank was accused of hiring the relatives of Chinese officials, with an aim to win banking deals. Of the total penalty amount, the U.S. Securities and Exchange Commission (SEC) will get $30 million and the Department of Justice (DOJ) will receive $47 million.
BCS.PRD BCS DB BCS.PRC BCS.PRA DGLD CS HSB 83SF UGLD 83SK HSBC.PRA HSBC HBCYF 47MC HCS.PRB DSLV VIIX CSSLF VIIZ HCS 0005 CSGKF BCS.PR HSEA HSEB ZIV USLV TVIX XIV

5
Global credit crunch has already taken hold

2018-07-05 thestar.com.my
Stock market sell-offs, volatility blow-ups, collapsing crypto currencies. They’re all the symptoms of an unfolding global credit squeeze, according to famed HSBC Holdings Plc bond guru Steven Major. It just happens to be developing at a snail’s pace.
GS.PRB GS.PRA HSB GS GLSSP HSBC.PRA HSBC HBCYF HCS.PRB JBK GSC GS.PRICL TFG HCS GSJ GS.PRJ 0005 GS.PRI GS.PRD GS.PRC HSEA HSEB GJS GS.PRN GS.PRK

1
PRESS DIGEST- Canada - July 5

2018-07-05 reuters
July 5 (Reuters) - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
HCS.PRB ENBBF ENB HCS TCN.DB.A HSB ENB 0005 TCN HSEA HSEB EBBNF HSBC.PRA HSBC HBCYF

5
‘Slo-mo credit crunch’ has already taken hold, bond guru says

2018-07-05 malaymail
Stock market selloffs, volatility blow-ups, collapsing crypto currencies. They’re all the symptoms of an unfolding global credit squeeze, according to famed HSBC Holdings Plc bond guru Steven Major. It just happens to be developing at a snail’s pace.
GS.PRB GS.PRA HSB GS GLSSP HSBC.PRA HSBC HBCYF HCS.PRB JBK GSC GS.PRICL TFG HCS GSJ GS.PRJ 0005 GS.PRI GS.PRD GS.PRC HSEA HSEB GJS GS.PRN GS.PRK

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...